High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$36.0M
$36,008,150
Total Sells (Filtered)
$260M
$260,925,000
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APGE
S
Apogee Therapeutics, Inc.
Fairmount Funds Management LLC
• Director
Discretionary SellΔOwn -85.4%
2026-01-22
$133,525,000MEGA
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -85.4%
|
2026-01-22 | $133,525,000MEGA | S | Form 4 |
|
COGT
S
Cogent Biosciences, Inc.
Fairmount Funds Management LLC
• Director
Discretionary SellΔOwn -38.9%
2026-01-22
$127,400,000MEGA
|
||||||
| COGT |
Cogent Biosciences, Inc.
|
Director
Discretionary SellΔOwn -38.9%
|
2026-01-22 | $127,400,000MEGA | S | Form 4 |
|
CBIO
P
CRESCENT BIOPHARMA, INC.
Fairmount Funds Management LLC
• Director
Discretionary BuyΔOwn +98.0%
2025-12-04
$19,999,999MEGAx2
|
||||||
| CBIO |
CRESCENT BIOPHARMA, INC.
|
Director
Discretionary BuyΔOwn +98.0%
|
2025-12-04 | $19,999,999MEGAx2 | P | Form 4 |
|
VRDN
P
Viridian Therapeutics, Inc.\DE
Fairmount Funds Management LLC
• Director
Discretionary BuyΔOwn +13.1%
2025-10-23
$9,999,990Whale
|
||||||
| VRDN |
Viridian Therapeutics, Inc.\DE
|
Director
Discretionary BuyΔOwn +13.1%
|
2025-10-23 | $9,999,990Whale | P | Form 4 |
|
ZBIO
P
Zenas BioPharma, Inc.
Fairmount Funds Management LLC
• Director
Discretionary BuyΔOwn +16.7%
2025-10-07
$6,008,161Whale
|
||||||
| ZBIO |
Zenas BioPharma, Inc.
|
Director
Discretionary BuyΔOwn +16.7%
|
2025-10-07 | $6,008,161Whale | P | Form 4 |